Back to company

Pharma Native ApS: Financial statements 2025

CVR: 44114976

Pharma Native ApS (CVR 44114976) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 989,531 and a net result of DKK 124,011 compared with DKK 77,485 the year before. That is a decrease of 35.6% compared with the year before. Equity amounted to DKK 255,959. The solvency ratio was 66.3%. The company had 1 employee in the financial year.

Gross Profit
989,531 kr.
Profit/Loss
124,011 kr.
Equity
255,959 kr.
Total Assets
386,227 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-990 t.124 t.256 t.1
2024-1.5 mio.77 t.267 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Pharma Native ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Pharma Native ApS: The 2024 annual report is outMar 11, 2025

Pharma Native ApS has published its annual report for 2024. Gross profit came to DKK 1,537,564, and the net result was DKK 77,485.

About Pharma Native ApS

Pharma Native ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2023. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Jacob Ekstrøm. The company is owned by Jacob Ekstrøm. In 2025, the company reported a gross profit of DKK 989,531 and a net result of DKK 124,011 compared with DKK 77,485 the year before. Equity amounted to DKK 255,959.

Other financial years